The cardiovascular efficacy of lipid-lowering drug targets is not entirely explained by apolipoprotein B reduction: Mendelian randomization evidence
File(s)R1_clean.docx (424.45 KB)
Accepted version
Author(s)
Gill, Dipender
Woolf, Benjamin
Zagkos, Loukas
Cronje, Helene T
Tzoulaki, Ioanna
Type
Journal Article
Date Issued
2023-08-14
Date Acceptance
2023-06-27
Citation
Circulation: Genomic and Precision Medicine, 2023, 16 (5), pp.490-492
ISSN
2574-8300
Publisher
American Heart Association
Start Page
490
End Page
492
Journal / Book Title
Circulation: Genomic and Precision Medicine
Volume
16
Issue
5
Copyright Statement
© 2023 American Heart Association, Inc.
Publication Status
Published